Nutriband Inc. Warrant
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA b… Read more
Nutriband Inc. Warrant (NTRBW) - Total Liabilities
Latest total liabilities as of July 2025: $1.68 Million USD
Based on the latest financial reports, Nutriband Inc. Warrant (NTRBW) has total liabilities worth $1.68 Million USD as of July 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nutriband Inc. Warrant - Total Liabilities Trend (2016–2025)
This chart illustrates how Nutriband Inc. Warrant's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nutriband Inc. Warrant Competitors by Total Liabilities
The table below lists competitors of Nutriband Inc. Warrant ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nation Group (Thailand) PCL
BK:NATION
|
Thailand | ฿891.56 Million |
|
Christina Lake Cannabis Corp
OTCQB:CLCFF
|
USA | $11.18 Million |
|
Altima Resources Ltd
PINK:ARSLF
|
USA | $19.94 Million |
|
Lease IT Public Company Limited
BK:LIT
|
Thailand | ฿536.69 Million |
|
Vo2 Cap Holding AB
ST:VO2
|
Sweden | Skr122.46 Million |
|
Alpcot Holding AB Series B
ST:ALPCOT-B
|
Sweden | Skr32.60 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Nutriband Inc. Warrant's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nutriband Inc. Warrant's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nutriband Inc. Warrant (2016–2025)
The table below shows the annual total liabilities of Nutriband Inc. Warrant from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-01-31 | $1.04 Million | -3.51% |
| 2024-01-31 | $1.08 Million | +22.13% |
| 2023-01-31 | $883.39K | +0.34% |
| 2022-01-31 | $880.38K | -68.73% |
| 2021-01-31 | $2.82 Million | +39.22% |
| 2020-01-31 | $2.02 Million | +401.81% |
| 2019-01-31 | $403.01K | +828.78% |
| 2018-01-31 | $43.39K | +196.83% |
| 2017-01-31 | $14.62K | +23.88% |
| 2016-01-31 | $11.80K | -- |